These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Successful daptomycin treatment for Staphylococcus lugdunensis endocarditis. Stair B; Vessels B; Overholser E; Zogleman B; Wall BM; Corbett C Am J Med Sci; 2012 Jul; 344(1):64-6. PubMed ID: 22314107 [TBL] [Abstract][Full Text] [Related]
9. [The second life of daptomycin: analysis of a successful come-back]. Decousser JW; Doucet Populaire F Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200 [No Abstract] [Full Text] [Related]
10. Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis. Bassetti M; Mikulska M; Schenone E; Nicolini L; Viscoli C Int J Antimicrob Agents; 2009 Sep; 34(3):290-1. PubMed ID: 19423300 [No Abstract] [Full Text] [Related]
11. Not so innocuous. Winchester DE; Lipinski MJ; Cupp ME; Sifri CD Am J Med; 2008 Oct; 121(10):855-7. PubMed ID: 18823853 [No Abstract] [Full Text] [Related]
12. Rhabdomyolysis and acute renal failure in a patient treated with daptomycin. Kazory A; Dibadj K; Weiner ID J Antimicrob Chemother; 2006 Mar; 57(3):578-9. PubMed ID: 16410267 [No Abstract] [Full Text] [Related]
13. [Staphylococcal endocarditis: valve prostheses and pacemakers]. Pachón Díaz J; de Alarcón González A Rev Clin Esp; 1997 Sep; 197 Suppl 2():33-7. PubMed ID: 9441321 [No Abstract] [Full Text] [Related]
14. High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides. Lichterfeld M; Ferraro MJ; Davis BT Int J Antimicrob Agents; 2010 Jan; 35(1):96. PubMed ID: 19896341 [No Abstract] [Full Text] [Related]
15. [Acute embolic myocardial infarction complicating bioprosthetic stentless aortic valve endocarditis]. Brambilla G; Ferratini M; Heyman J; Racca V; Danna P; Lemma M; Antona C Ital Heart J Suppl; 2003 Jul; 4(7):594-7. PubMed ID: 14558288 [TBL] [Abstract][Full Text] [Related]
16. [Safety of daptomycin in patients with renal impairment]. Azanza JR; Quetglas EG Med Clin (Barc); 2010 Dec; 135 Suppl 3():55-9. PubMed ID: 21477705 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure. Joson J; Grover C; Downer C; Pujar T; Heidari A J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600 [No Abstract] [Full Text] [Related]
18. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Bhavnani SM; Rubino CM; Ambrose PG; Drusano GL Clin Infect Dis; 2010 Jun; 50(12):1568-74. PubMed ID: 20462352 [TBL] [Abstract][Full Text] [Related]
19. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus. Liu CY; Wang JL; Huang YT; Hsueh PR Int J Antimicrob Agents; 2008 Dec; 32(6):544-5. PubMed ID: 18789850 [No Abstract] [Full Text] [Related]